Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Tagasi
11 aprill 2017, 11:20
3655

Public Health England Has Answered To #WhereIsPrEP Call

Public Health England Has Answered To #WhereIsPrEP Call - pilt 1

In response to the petition calling for starting a trial submitting the pre-exposure prophylaxis (PreP) drug administration to 10,000 people over three years, the British government has updated the PrEP Impact Trial today.

In a press release published in December 2016, NHS England proclaimed that its trial submitting the pre-exposure prophylaxis (PreP) drug administration to 10,000 people over three years would occur in the "early financial year 2017/18". But while the new fiscal year started, no progress has been made until today.

"Our aim is to have the trial started by the summer of 2017," the British government official statement announced today.

Public Health England Prevention Innovation Fund in 2017 to 2018 is seeking proposals that will address knowledge, awareness, and understanding of PrEP and other PrEP-related questions, especially in currently under-served populations in the community (e.g. higher-risk heterosexuals, black and minority ethnic group gay men and transgender communities). To register interest in the fund, please send an email with your name, email address and organization name to [email protected].

As the official statement guarantees, PrEP drug supply will be paid for and secured by NHS England.

Autor: Liliya Ten

Jaga suhtlusvõrkudes